Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients’, pharmacists’ and GPs’ experiences and expectations

Abstract

BackgroundThis study aimed to use marketing theory to examine the views of patients, pharmacists and general practitioners (GPs) on how community pharmacies are currently used and to identify how community pharmacy services may be better integrated within the primary care pathway for people with long-term conditions (LTCs).MethodsA qualitative research design was used. Two focus groups were conducted with respiratory patients (n = 6, 5) and two with type 2 diabetes patients (both n = 5). Two focus groups were held with pharmacists (n = 7, 5) and two with GPs (both n = 5). The “7Ps marketing mix” (“product”, “price”, “place”, “promotion”, “people”, “process”, “physical evidence”) was used to frame data collection and analysis. Data was analysed using thematic analysis.ResultsDue to the access and convenience of community pharmacies (“place”), all stakeholder groups recommended using community pharmacies over GP practices for services such as management of minor ailments, medication reviews and routine check-ups for well managed LTCs (“product”). All stakeholder groups preferred pharmacy services with clear specifications which focused on specific interventions to reduce variability in service delivery and quality (“process”). However, all stressed the importance of having an appropriate system to share relevant information, allowing pharmacists and GPs two-way flow (“process”). Pharmacists and GPs mentioned difficulties in collaborating with each other due to inter-professional tensions arising from funding conflicts, which leads to duplication of services and inefficient workflow within the primary care pathway (“people”). Patients and GPs were sometimes doubtful of community pharmacies’ potential to expand services due to limited space, size and poor quality consultation rooms (“physical evidence”). However, all stakeholder groups recommended promoting community pharmacy services locally and nationally (“promotion”). Patients felt the most effective form of promotion was first-hand experience of high quality pharmacy services and peer word-of-mouth. The added value of using pharmacy services was faster access and convenience for patients, and freeing up GPs’ time to focus on more complex patients (“value”).ConclusionsUsing the 7Ps marketing mix highlighted factors which could influence utilisation and integration of community pharmacy services within the primary care pathway for patients with LTCs. Further research is needed to identify their relative importance.Electronic supplementary materialThe online version of this article (10.1186/s12875-019-0912-0) contains supplementary material, which is available to authorized users.

Independent prescribing in primary care: A survey of patients', prescribers' and colleagues' perceptions and experiences

“…However, fostering inter‐professional relationships could be challenging for IPs in primary care settings such as community pharmacy where contact with physicians and other healthcare professionals is often limited (Bradley, Ashcroft, & Crossley, ; Hindi, Jacobs, & Schafheutle, ; Noblet, Marriott, Graham‐Clarke, & Rushton, ). Moreover, IPs could also encounter difficulties accessing patient records, ongoing training and clinical supervision depending on their healthcare settings (Courtenay et al, ; Hindi, Schafheutle, & Jacobs, ; Stenner et al, ; Weeks, George, Maclure, & Stewart, ). Therefore, the implementation process for independent prescribing should account for organisational complexities within different primary care settings to ensure IPs have appropriate access to patient records, clinical supervision, ongoing training and CPD.…”

The Community Pharmacist: Perceived Barriers and Patient-Centered Care Communication

“…Among these, community pharmacists have been defined as "the first port of call" among the professionals in the health sector thanks to their easy accessibility to the public [7,8]. They can also be described as "primary care pharmacists," thus recognizing their contribution in delivering primary health care services, including management of chronic conditions (e.g., hypertension, treatment of minor ailments, administration of vaccinations) [9][10][11][12].…”

Professional Roles of General Practitioners, Community Pharmacists and Specialist Providers in Collaborative Medication Deprescribing - A Qualitative Study

“…However, whereas Bardet et al [19] claim the quality of communication to be determining rather than its quantity, our ndings stress the importance of structural preconditions for such communication, like the prescription transparency across providers. For CPs' access to more comprehensive patient information including medical records this has been asserted earlier [20]. As in the German setting, another structural determinant of GP-pharmacist tension may lie in CPs' nancial con ict of interest [27], advocating for better reimbursement of patient-oriented medication optimization services.…”